Overview
Novel drug developer.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: $55M (Series D), Jul 13, 2026.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 13, 2026 | $55M · Series D | Biometas, YD Capital, 嘉善国投, 德同资本, 浦东创投集团, 深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）, 百奥维达, 科源制药, 致凯资本, 苇渡资本 | No source link |
Evidence Yaowumuchang raises USD 55 million in Series D financingOn 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer. Translated source brief, not a quotation. Check the original before citing. Sources · 0
Biometas, YD Capital, 嘉善国投, 德同资本, 浦东创投集团, 深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）, 百奥维达, 科源制药, 致凯资本, 苇渡资本 | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 13, 2026 | — · Series D | Biometas, YD Capital, 嘉善国投, 德同资本, 浦东创投集团, 深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）, 百奥维达, 科源制药, 致凯资本, 苇渡资本 | No source link |
Evidence Yaowumuchang raises USD 55 million in Series D financingOn 2026-07-13, according to Xiniu Data, Yaowumuchang completed Series D financing, raising USD 55 million. Investors were lead investor Pudong Venture Capital Group, participating investor Zhikai Capital, participating investor Shenzhen City Luohudonghairuizhi Pharmaceutical Industrial Investment Partnership (Limited Partnership), participating investor Keyuanzhiyao, participating investor Baiaoweida, participating investor YD Capital, participating investor Jiashanguotou, participating investor Detong Capital, participating investor Weidu Capital, participating investor Biometas. The company is a novel drug developer. Translated source brief, not a quotation. Check the original before citing. Sources · 0
Biometas, YD Capital, 嘉善国投, 德同资本, 浦东创投集团, 深圳市罗湖东海睿智医药产业投资合伙企业（有限合伙）, 百奥维达, 科源制药, 致凯资本, 苇渡资本 | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
原创新药研发商